Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dewi Ramdani"'
Publikováno v:
Jurnal Kesehatan, Vol 13, Iss 2, Pp 272-278 (2022)
Covid-19 is a novel viral disease resulting in many casualties around the world, including in Indonesia. By the 19th of January 2022, the death rate is 3.36% higher than the world’s, i.e., 1.64%. Covid-19 -related death is caused by several factors
Externí odkaz:
https://doaj.org/article/3318ffa4632047af9ed5b7029200131b
Autor:
Rika Yulia, Putri Ayu Irma Ikasanti, Fauna Herawati, Ruddy Hartono, Puri Safitri Hanum, Lestiono, Dewi Ramdani, Abdul Kadir Jaelani, Kevin Kantono, Heru Wijono
Publikováno v:
Pathophysiology, Vol 29, Iss 1, Pp 92-105 (2022)
The clinical manifestations associated with COVID-19 disease is mainly due to a dysregulated host response related to the overexpression of inflammatory markers. Until recently, only remdesivir had gained FDA approval for COVID-19 hospitalized patien
Externí odkaz:
https://doaj.org/article/438680370a4e4f84ac93e63f188faa73
Autor:
Fauna Herawati, Eka Yuliantini Fahmi, Noer Aulia Pratiwi, Dewi Ramdani, Abdul Kadir Jaelani, Rika Yulia, Retnosari Andrajati
Publikováno v:
Journal of Public Health Research, Vol 10, Iss 3 (2021)
Background: Four oral anti-tuberculosis drugs are conceived to be the most effective ones to eradicate Mycobacterium tuberculosis bacteria and to obviate the resistant organisms. However, the patients' adherence and medication discrepancies are obsta
Externí odkaz:
https://doaj.org/article/cac3cd7cea214c30bd7594648f85d998
Publikováno v:
JBMP (Jurnal Bisnis, Manajemen dan Perbankan). 7:89-106
The success of the hospital in carrying out its functions is influenced by several factors, among which the most dominant is human resources. Human resources are one of the important factors to be able to provide quality and comprehensive services in
Publikováno v:
International Journal of Pharma Research and Health Sciences. 9:3286-3290
Objective: Low dose aspirin (LDA) is one of platelet aggregation agents in high-risk pregnancy that is believed to prevent complication by inhibiting thromboxane A2 as a strong vasoconstrictor in platelet. It can inhibit platelet aggregation involved